BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), an international pharmaceutical company, today announced that Daniel P. Getman, Ph.D., President, Kansas City Area Life Sciences Institute (KCALSI) and formerly Vice President, Pfizer Global Research and Development and Director of Pfizer’s St. Louis laboratories, has been appointed to Sucampo Pharmaceuticals’ Board of Directors.
